Author

Karen Isaacs

Observed names: K Isaacs, K. Isaacs

Observed institutions: Cardiff and Vale University Health Board, University Hospitals Birmingham NHS Foundation Trust, University of Dundee, Ninewells Hospital, University of Manchester, National Institute for Health and Care Research, University of Oxford, MRC University of Glasgow Centre for Virus Research, Centre for Inflammation Research, Imperial College London, University of Birmingham, University of Edinburgh

OpenAlex ID: A5111169236

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

2022 · R A Evans, O C Leavy, et al. · The Lancet Respiratory Medicine · 413

PDF

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis

2024 · Krithika Loganath, Neil J. Craig, et al. · JAMA · 159

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

2024 · Shelagh B Coutts, Sandeep Ankolekar, et al. · The Lancet · 141

PDF

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 107

PDF

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

2023 · Betty Raman, Celeste McCracken, et al. · The Lancet Respiratory Medicine · 57

PDF

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35

Accelerated immune ageing is associated with COVID-19 disease severity

2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34

PDF

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 24

PDF

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23

PDF

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14

PDF

Long COVID research: an update from the PHOSP-COVID Scientific Summit

2023 · Christopher E Brightling, Rachael A Evans, et al. · The Lancet Respiratory Medicine · 11

PDF

Thrombolysis With Tenecteplase for Minor Disabling Stroke

2025 · Yiran Zhang, Brian H. Buck, et al. · JAMA Neurology · 8

Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis

2026 · Neil J. Craig, Krithika Loganath, et al. · JAMA Cardiology · 2

Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 Trial

2025 · Amy Y. X. Yu, Shabnam Vatanpour, et al. · Journal of the American Heart Association · 2

Works count: 16

Citation count: 1,180

H-index: 12

I10-index: 13